Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The tumor suppressor protein p53 has been well documented as a transcriptional activator involved in the regulation of a number of critical genes involved in the cell cycle, response to DNA damage, and apoptosis. Activation by p53 requires the interaction of the protein with a consensus binding site consisting of two half-sites, each comprising two copies of the sequence PuPuPuC(A/T) arranged head-to-head and separated by 0-13 base pairs. In addition to activation, p53 has been shown to be a potent repressor of transcription. However, the basis for p53-mediated repression is not well understood and has been proposed to occur indirectly through interactions with other promoter-bound transcription factors. In the present study, we show that p53 can repress transcription directly by binding to a novel head-to-tail (HT) site within the MDR1 promoter. A mutation that disrupted p53 binding to the MDR1 HT site blocked p53-mediated repression of the MDR1 promoter in transfection assays. Replacement of the HT site with a head-to-head (HH) site converted the activity of p53 from repression to activation, indicating that simple recruitment of p53 to the promoter is not sufficient for repression and that the orientation of the binding element determines the fate of p53-regulated promoters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
Robertson, K. D., & Jones, P. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6457 · Cited by 352
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15237 · Cited by 144
Research works printed but not linked: 35
- May, 1999, Oncogene, 18, 7621, 10.1038/sj.onc.1203285 · DOI · Paper page
- el-Deiry, 1998, Semin. Cancer Biol., 8, 345, 10.1006/scbi.1998.0097 · DOI · Paper page
- Venot, 1998, EMBO J., 17, 4668, 10.1093/emboj/17.16.4668 · DOI · Paper page
- Kanaya, 2000, Clin. Cancer Res., 6, 1239
- Ohlsson, 1998, Endocrinology, 139, 1101, 10.1210/endo.139.3.5832 · doi:10.1210/endo.139.3.5832 · Paper page
- Yun, 1999, J. Biol. Chem., 274, 29677, 10.1074/jbc.274.42.29677 · DOI · Paper page
- Iotsova, 1996, Cell. Growth Differ., 7, 629
- Subbaramaiah, 1999, J. Biol. Chem., 274, 10911, 10.1074/jbc.274.16.10911 · DOI · Paper page
- Kubicka, 1999, J. Biol. Chem., 274, 32137, 10.1074/jbc.274.45.32137 · DOI · Paper page
- Sun, 1999, J. Biol. Chem., 274, 11535, 10.1074/jbc.274.17.11535 · DOI · Paper page
- Lee, 1999, Mol. Cell. Biol., 19, 1279, 10.1128/MCB.19.2.1279 · DOI · Paper page
- Ori, 1998, EMBO J., 17, 544, 10.1093/emboj/17.2.544 · DOI
- Seto, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 12028, 10.1073/pnas.89.24.12028 · DOI · Paper page
- Truant, 1993, J. Biol. Chem., 268, 2284, 10.1016/S0021-9258(18)53769-8 · DOI · Paper page
- Farmer, 1996, Mol. Cell. Biol., 16, 4295, 10.1128/MCB.16.8.4295 · DOI · Paper page
- Thut, 1995, Science, 267, 100, 10.1126/science.7809597 · DOI · Paper page
- van Veen, 1998, Adv. Exp. Med. Biol., 456, 145, 10.1007/978-1-4615-4897-3_8 · DOI
- Johnstone, 2000, Trends Biochem. Sci, 25, 1, 10.1016/S0968-0004(99)01493-0 · DOI · Paper page
- Chin, 1992, Science, 255, 459, 10.1126/science.1346476 · DOI · Paper page
- Zastawny, 1993, Oncogene, 8, 1529
- Thottassery, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 11037, 10.1073/pnas.94.20.11037 · DOI · Paper page
- Watanabe, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 8490, 10.1073/pnas.150104097 · DOI
- Morrow, 1994, J. Biol. Chem., 269, 10739, 10.1016/S0021-9258(17)34121-2 · DOI
- Jin, 1998, Mol. Cell. Biol., 18, 4377, 10.1128/MCB.18.7.4377 · DOI · Paper page
- Hu, 2000, J. Biol. Chem., 275, 2979, 10.1074/jbc.275.4.2979 · DOI · Paper page
- Resnick-Silverman, 1998, Genes Dev., 12, 2102, 10.1101/gad.12.14.2102 · DOI · Paper page
- Sampath, 2000, Proc. Am. Assoc. Cancer Res., 41, 841
- Cornwell, 1993, J. Biol. Chem., 268, 19505, 10.1016/S0021-9258(19)36544-5 · DOI · Paper page
- Sundseth, 1997, Mol. Pharmacol., 51, 963, 10.1124/mol.51.6.963 · DOI
- Funk, 1992, Mol. Cell. Biol., 12, 2866
- Desdouets, 1996, FEBS Lett., 385, 34, 10.1016/0014-5793(96)00330-4 · DOI
- Innocente, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 2147, 10.1073/pnas.96.5.2147 · DOI · Paper page
- Waterman, 1995, EMBO J., 14, 512, 10.1002/j.1460-2075.1995.tb07027.x · DOI
- Gu, 1997, Cell, 40, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- Murphy, 1999, Genes Dev., 13, 2490, 10.1101/gad.13.19.2490 · DOI · Paper page
Cited by
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
“Third, gene repression could be mediated by unique p53 “repression” elements to which p53 binds directly (Godar et al., 2008; Johnson et al., 2001).”
BackgroundTranscriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression
Schwartzenberg-Bar-Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 726
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
Transcriptional regulation by p53: one protein, many possibilities
Laptenko, O., & Prives, C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 505
Godar, S., Ince, T. A., Bell, G. W., Feldser, D., Donaher, J. L., Bergh, J., Liu, A., Miu, K., Watnick, R. S., Reinhardt, F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.006 · Cited by 456
Self-citationMechanisms of transcriptional regulation by p53
Sullivan, K. D., Galbraith, M. D., Andrysik, Z., & Espinosa, J. M. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.174 · Cited by 446
Transcriptional regulation of ABC drug transporters
Scotto, K. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206950 · Cited by 392
Self-citationModulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Li, M., He, Y., Dubois, W., Wu, X., Shi, J., & Huang, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.020 · Cited by 264
“Interestingly, earlier studies have suggested that the length of the spacer dictates the transcriptional outcome (activation versus repression) for p53-repressed genes, such as the Survivin and Mdr1 genes (Hoffman et al., 2002; Johnson et al., 2001).”
Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
Chen, K. G., & Sikic, B. I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1590 · Cited by 197
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Spurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114
Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic
Verfaillie, A., Svetlichnyy, D., Imrichova, H., Davie, K., Fiers, M., Kalender Atak, Z., Hulselmans, G., Christiaens, V., & Aerts, S. (2016) · Genome Research · doi:10.1101/gr.204149.116 · Cited by 82
Reed, K., Hembruff, S. L., Sprowl, J. A., & Parissenti, A. M. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.1 · Cited by 56
Chen, K. G., Sale, S., Tan, T., Ermoian, R. P., & Sikic, B. I. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.906 · Cited by 52
Metadata
- Authors
- Johnson, R. A., Ince, T. A., & Scotto, K. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 276
- Issue
- 29
- Pages
- 27716-27720
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2010488171
- Cited by
- 157
- References
- 5
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7032 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.